SOL SPA (SLSPF) Stock Price & Analysis
SLSPF Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- $6.06B
- Enterprise Value
- $5.88B
- Total Cash (Recent Filing)
- $312.81M
- Total Debt (Recent Filing)
- $878.27M
- Price to Earnings (P/E)
- 31.3
- Beta
- N/A
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
Recurring annual revenue growth indicates sustained demand and an expanding operating base rather than reliance on a single reporting period. Continued top-line progress can support reinvestment, improve scale economics, and strengthen the company’s earnings capacity over the next several quarters.
Stable Operating Margins
Stable mid-teens EBIT margins and consistently strong EBITDA margins demonstrate resilient operating profitability within the company’s sector. This provides a durable earnings foundation and suggests that revenue growth is translating into dependable operating performance despite some variability lower in the income statement.
Healthy Returns On Equity
Consistently healthy mid-teens returns on equity indicate that the business has generated meaningful profitability from its capital base over time. Combined with a generally reasonable historical leverage profile, this supports evidence of effective capital deployment and an established earnings model.
Bears Say
Declining Free Cash Flow
Declining free cash flow weakens the quality of reported profits and reduces internally generated funds available for investment, debt reduction, or shareholder returns. If the pressure persists, heavier capital spending or weaker cash efficiency could constrain financial flexibility over the coming quarters.
Higher 2025 Leverage
The 2025 increase in total debt and debt-to-equity reduces balance-sheet flexibility compared with the company’s prior position. Higher leverage can make the business more sensitive to weaker earnings or elevated interest rates, while limiting room to fund growth and absorb operating setbacks.
Gross Margin Volatility
Large fluctuations in gross margin introduce uncertainty into earnings quality even though EBIT and EBITDA margins have remained comparatively stable. Persistent variability may reflect changing input costs, pricing, or product mix, making future profitability less predictable and increasing execution requirements.
SOL SPA News
SLSPF FAQ
What is SOL SPA’s market cap?
When is SOL SPA’s upcoming earnings report date?
How were SOL SPA’s earnings last quarter?
Is SOL SPA overvalued?
Does SOL SPA pay dividends?
What is SOL SPA’s EPS estimate?
What happened to SOL SPA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SOL SPA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SOL SPA
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Aldo Fumagalli Romario
- Employees
- 8,000
- Website
- www.solgroup.com
- Address
- Via Borgazzi, 27, Monza, MI, 20900, IT


